Annexon biosciences to present at the 42nd annual j.p. morgan healthcare conference

Brisbane, calif., dec. 27, 2023 (globe newswire) -- annexon, inc. (nasdaq: annx) a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that douglas love, president and chief executive officer, will present at the 42nd annual j.p. morgan healthcare conference on wednesday, january 10, 2024 at 2:15 p.m. pt in san francisco.
ANNX Ratings Summary
ANNX Quant Ranking